PharmD | PhD Candidate in Pharmacy (Cellular and Molecular Biology) at @iMedULisboa interested in immunogenic cell death and inflammation in liver diseases
The time to think and inquire are precious.
Inquiring means to contemplate a problem without needing an immediate answer, to sit in the unknown long enough that different kinds of answers emerge. Important part of the process of discovery.
https://t.co/vWgTsld4uJ
8/ Fatty liver affects ➕ than 1/3 of the adult population and can lead to liver cirrhosis or liver cancer.
🔎The #CaixaResearch project led by @RuiCastroHD (@iMedULisboa) has discovered a biomarker that will enable its early detection.
https://t.co/RjgpbcFE2X
Very exciting and promising results presented by @AndreCardador on the role of RIPK3 in the development of HCC
🎯Inhibition of RIPK3 impacts on HCC burden
🎯RIPK3 modulates the immune microenvironment ⏩ novel target for immunotherapy?
@MartaBAfonso@CRodriguesUL@iMedULisboa
Last Friday, I had the opportunity to present the latest results of my PhD at the #NAFLDSummit 2022. Thank you @EASLnews for this enriching conference with the latest updates about NAFLD management, research, and the biggest challenges in the design of clinical trials. See you!
Decorreu esta noite, mais um Fórum Discussão - “ À conversa com a Bastonária da Ordem dos Farmacêuticos “ organizado pela ANF, onde pudemos discutir o Futuro da Profissão Farmacêutica, considerando as Tecnologias de Saúde, o SNS e a formação dos futuros Farmacêuticos na Academia.